Gillian McGovern, Associate Editor

The CRAFT (NCT04551521) trial is still ongoing to assess findings in the remaining patient arms.

Using ultrasound and clinicopathological characteristics, the studied nomograms effectively evaluated recurrence risk in HR-/HER2+ and HR+/HER2+ breast cancer.

Seroconversion was observed in 95.8% of participants but dropped to 75.6% at the 4-year follow-up.

The authors also found that there was a higher frequency of miscarriages compared with women who did not have asthma.

Additionally, the authors are concerned by the lack of increase in depressive or anxiety diagnoses, indicating potential barriers to care.

The authors urge that screening, prevention, and treatment of anxiety and depression should be important health care priorities for youth who have chronic pain.

The investigators of the phase 3b trial (NCT04838444) will continue to follow up with patients for up to 10 years.

To help with treatment response and compliance as well as optimize treatment, communication between patients and health care providers is necessary.

Despite the new human case, which is not known to be related to animal exposure, the CDC emphasizes that risk to the general public remains low.

Presenter Krish Patel, MD, discusses the use of epcoritamab (Epkinly; AbbVie) and glofitamab (Columvi; Genentech) in aggressive B-cell lymphomas as monotherapies and in combination regimens.

The study authors suggest that annual screening for women aged 40 and older may be beneficial, but warn of the increased risk of false positive results.

Disease-related factors include several prognostic scoring systems, such as DIPSS, whereas patient-related factors involve age, comorbidities, spleen size, and anemia.

A pharmacist with Allegheny Health Network discusses travel vaccines and what resources are valuable when determining which vaccinations are needed prior to travel.

Rather than “trial-and-erroring” transplants for patients, experts should instead select transplants that are precise, personalized, and predictable.

Lauren Posteraro, PharmD, a pharmacist with AHN, discusses how misinformation and access to technology can contribute to vaccine hesitancy.

The authors stress that health care providers should explain false positive results to their patients, reassure them that results may be negative, and stress the significance of continued screenings.

The findings demonstrate a need for additional health care provider training and resources for birthing people with intellectual and developmental disabilities.

A recent study found that a weight-adjusted waist index was an independent predictor of all-cause-, cardiovascular-, cancer-, and respiratory-related mortality in patients with asthma.

The risk of late-stage diagnosis was higher for Asian, Black, and Native Hawaiian or Other Pacific Islander adolescent and young adult patients with cancer.

Cases have been detected in 33 US states so far this year, and the virus has recently hospitalized the former Chief Medical Advisor to the President of the US Anthony Fauci.

The exhaled breath condensate mask was able to successfully monitor and accurately detect breath for nitrate in patients with asthma or chronic obstructive pulmonary disease.

Those with an aneurysm diagnosis who were younger than 40 years of age were observed to have an even higher risk.

The author suggest how to improve the representation of women, older adults, and minorities in clinical research that will require effort from a broad range of stakeholders.

Using 1 nicotine-containing electronic cigarette was significantly correlated with an increase in residual volume and total lung capacity in patients with asthma.

Pharmacists can help facilitate more organized efforts to improve measles vaccination uptake for children aged 5 and younger by identifying socio-demographic gaps within this population.

Pharmacists support treatment adherence as well as monitor adverse effects, drug-drug interactions, and quality of life.

Previously, the device was indicated for the management of type 1 diabetes in patients aged 2 years and older.

The indication is for adults with relapsed or refractory chronic lymphocytic leukemia or small lymphocytic lymphoma who were treated with at least 2 prior lines of therapy.

In Finland, season of birth, notably autumn and winter, was associated with the development of asthma and allergic rhinitis.

The researchers found that unusual and dramatic changes in weather as well as heavy rainfall helped aid in the pathogen’s evolutionary change.